Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-191220
Filing Date
2025-08-28
Accepted
2025-08-28 16:01:00
Documents
17
Effectiveness Date
2025-08-28

Document Format Files

Seq Description Document Type Size
1 S-8 d936758ds8.htm S-8 56823
2 EX-5.1 d936758dex51.htm EX-5.1 15308
3 EX-23.1 d936758dex231.htm EX-23.1 1730
4 EX-FILING FEES d936758dexfilingfees.htm   iXBRL EX-FILING FEES 12517
5 GRAPHIC g936758g0828035834389.jpg GRAPHIC 2494
6 GRAPHIC g936758g0828035834569.jpg GRAPHIC 3385
7 GRAPHIC g936758g0828035834720.jpg GRAPHIC 3744
  Complete submission text file 0001193125-25-191220.txt   220217

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d936758dexfilingfees_htm.xml XML 4892
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
VivoSim Labs, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-289913 | Film No.: 251273200
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)